Nest Health
Genomics Software Solutions for Health Systems
Company Overview
Snapshot
Founded in February 2022 by Moran Snir and Guy Snir, Nest Health operates with 11–50 employees. The company has raised $8.5 million across one funding round from 7 investors, with B Capital leading the Seed round. In January 2023, Nest Genomics secured $8.5 million to enhance patient access to genetic information.
Business overview
Nest Health develops a genomics software platform designed for health systems. Its core technology provides electronic health record-integrated tools for healthcare providers, including patient triage, test ordering, and clinical decision support for managing genetic results based on current clinical guidelines. The company's platform also offers features for patients, such as personalized educational content, results sharing, and screening reminders, serving health systems, clinics, drug-makers, and payers in the Health Tech & Life Sciences sector.
Strategic signal
In January 2023, Nest Genomics raised $8.5 million to expand access to genetic information for patients. This funding validates the market need for integrated genomics solutions within healthcare and signals investor confidence in the company's approach to making genetic data more accessible and actionable for both providers and patients.
Company Intelligence Q&A
- When was Nest Health founded?
- Nest Health was founded in February 2022 by Moran Snir and Guy Snir.
- How much capital has Nest Health raised to date?
- Nest Health has raised $8.5 million in total funding.
- Which investors participated in Nest Health's funding round?
- In January 2023, Nest Health secured funding from investors including B Capital and LionBird.
- What was a key development for Nest Health in January 2023?
- In January 2023, Nest Health raised $8.5 million to increase patient access to genetic information.
- What is Nest Health's primary focus?
- Nest Health focuses on providing genomics software solutions for health systems, aiming to integrate genetic information into clinical care and empower patients with access to their genetic data.